Original Article
Journal of Cerebral Blood Flow & Metabolism (2008) 28, 1341–1352; doi:10.1038/jcbfm.2008.28; published online 16 April 2008
Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii
Arieh Moussaieff1,2, Na'ama A Shein2, Jeanna Tsenter2,3, Savvas Grigoriadis4, Constantina Simeonidou5, Alexander G Alexandrovich2, Victoria Trembovler2, Yinon Ben-Neriah6, Michael L Schmitz7, Bernd L Fiebich8, Eduardo Munoz9, Raphael Mechoulam1 and Esther Shohami2
- 1Department of Medicinal Chemistry and Natural Products, Medical Faculty, Hebrew University, Jerusalem, Israel
- 2Department of Pharmacology, School of Pharmacy, Hebrew University, Jerusalem, Israel
- 3Rehabilitation Center, Hadassah Medical Center, Hebrew University, Jerusalem, Israel
- 4Laboratory of Experimental Neurology, AHEPA University Hospital, Thessaloniki, Greece
- 5Laboratory of Physiology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
- 6The Lautenberg Center for Immunology, Hadassah Medical School, Hebrew University, Jerusalem, Israel
- 7Institute of Biochemistry, Medical Faculty, Justus-Liebig-University, Giessen, Germany
- 8Department of Psychiatry, University of Freiburg Medical School, Freiburg, Germany
- 9Departamento Biologia Celular, Fisiologia e Inmunologia, Facultad de Medicina, Universidad de Cordoba, Cordoba, Spain
Correspondence: Professor E Shohami, Department of Pharmacology, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem 91120, Israel. E-mail: esty@cc.huji.ac.il
Received 2 October 2007; Revised 10 March 2008; Accepted 13 March 2008; Published online 16 April 2008.
Abstract
Boswellia resin has been used as a major anti-inflammatory agent and for the healing of wounds for centuries. Incensole acetate (IA), isolated from this resin, was shown to inhibit the activation of nuclear factor-
B, a key transcription factor in the inflammatory response. We now show that IA inhibits the production of inflammatory mediators in an in vitro model system of C6 glioma and human peripheral monocytes. Given the involvement of postinjury inflammation in the pathophysiology and outcome of traumatic brain injury, we examined the effect of IA on the inflammatory process and on the recovery of neurobehavioral and cognitive functions in a mouse model of closed head injury (CHI). In the brains of post-CHI mice, IA reduced glial activation, inhibited the expression of interleukin-1
, and tumor necrosis factor-
mRNAs, and induced cell death in macrophages at the area of trauma. A mild hypothermic effect was also noted. Subsequently, IA inhibited hippocampal neurodegeneration and exerted a beneficial effect on functional outcome after CHI, indicated by reduced neurological severity scores and improved cognitive ability in an object recognition test. This study attributes the anti-inflammatory activity of Boswellia resin to IA and related cembranoid diterpenes and suggests that they may serve as novel neuroprotective agents.
Keywords:
Boswellia, cembranoids, incensole acetate, inflammation, neuroprotection, traumatic brain injury
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Crystal structure of human osteoclast cathepsin K complex with E-64Nature Structural Biology Correspondence (01 Feb 1997)
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibitionJournal of Cerebral Blood Flow & Metabolism Original Article
Heat acclimation increases hypoxia-inducible factor 1α and erythropoietin receptor expression: implication for neuroprotection after closed head injury in miceJournal of Cerebral Blood Flow & Metabolism Original Article
The Ras Inhibitor S-trans, trans-Farnesylthiosalicylic Acid Exerts Long-Lasting Neuroprotection in a Mouse Closed Head Injury ModelJournal of Cerebral Blood Flow & Metabolism Original Article

